Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 2

3(42.9%)

N/A

2(28.6%)

Phase 3

1(14.3%)

Phase 4

1(14.3%)

7Total

Phase 2(3)

N/A(2)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT02268786Not ApplicableCompleted

Single Embryo TrAnsfeR of Euploid Embryo

Role: collaborator

NCT02673125Not ApplicableUnknown

Prospective Paired Study on the Effectiveness of MitoGrade

Role: lead

NCT02000349Phase 2Unknown

Comparison of Frozen-thawed Embryo Transfers and Fresh Embryo Transfers With Whole Chromosome Analysis Using Next Generation Sequencing

Role: lead

NCT01946945Phase 2Unknown

Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis

Role: lead

NCT01546350Phase 2Suspended

Preimplantation Genetic Diagnosis Using Blastocyst Biopsy and Array CGH

Role: lead

NCT01332643Phase 3Terminated

Preimplantation Genetic Diagnosis (PGD) by Array Comparative Genome Hybridization (CGH) and Blastocyst Biopsy

Role: lead

NCT00646893Phase 4Suspended

Preimplantation Genetic Diagnosis for the Indication of Advanced Reproductive Age

Role: lead

All 7 trials loaded